CytRx says FDA to decide on study enrollments in January

CytRx says FDA to decide on study enrollments in January

(Reuters) – CytRx Corp said interim data showed its experimental brain cancer drug was effective in a mid-stage study and a partial clinical hold on enrollment could be lifted this month. The U.S. Food and Drug Administration had put a partial hold on …

6
Like
Save

Comments

Write a comment

*